Cargando…

Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications

OBJECTIVES: Adrenocortical scintigraphy for patients with primary aldosteronism (PA) without discontinuation or modification of antihypertensive medications is of concern because of drug interference with the renin–angiotensin–aldosterone system. We report the surgical outcomes of patients with PA l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Chia-Hui, Yang, Stephen Shei-Dei, Tsai, Yao-Chou, Kuo, Shi-Wen, Cherng, Shiou-Chi, Lu, Ching-Chu, Yen, Ruoh-Fang, Wu, Vin-Cent, Hu, Ya-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047325/ https://www.ncbi.nlm.nih.gov/pubmed/30069126 http://dx.doi.org/10.4103/tcmj.tcmj_106_17

Ejemplares similares

Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism
por: Araujo-Castro, Marta, et al.
Publicado: (2023)

Imaging of hepatic drug transporters with [(131)I]6-β-iodomethyl-19-norcholesterol
por: Kobayashi, Masato, et al.
Publicado: (2019)

Ectopic Cortisol-producing Adrenocortical Adenoma Detected by 131I-6β-iodomethyl-norcholesterol Scintigraphy
por: Sato, Seisuke, et al.
Publicado: (2020)

Author Correction: Imaging of hepatic drug transporters with [(131)I]6-β-iodomethyl-19-norcholesterol
por: Kobayashi, Masato, et al.
Publicado: (2019)

Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan
por: Wu, Ming-Hsien, et al.
Publicado: (2019)

Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series
por: Lee, Jeongmin, et al.
Publicado: (2021)

Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
por: Wu, Che-Hsiung, et al.
Publicado: (2013)

1,4-Bis(iodomethyl)benzene
por: McAdam, C. John, et al.
Publicado: (2009)

(S)-2-(Iodomethyl)-1-tosylpyrrolidine
por: Wang, Ya-Wen, et al.
Publicado: (2007)

Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus
por: Chang, Chia-Hui, et al.
Publicado: (2018)

Primary Aldosteronism and Cerebrovascular Diseases
por: Chen, Zheng-Wei, et al.
Publicado: (2018)

Aldosterone-producing adenoma is associated with urolithiasis in primary aldosteronism
por: Kang, Victor Jing-Wei, et al.
Publicado: (2023)

Two-Step Azidoalkenylation of Terminal Alkenes Using Iodomethyl Sulfones
por: Millius, Nicolas, et al.
Publicado: (2019)

Endothelial Dysfunction in Primary Aldosteronism
por: Chen, Zheng-Wei, et al.
Publicado: (2019)

Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research
por: Wu, Wan-Chen, et al.
Publicado: (2021)

Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism
por: Cheng, Chung-Yi, et al.
Publicado: (2021)

Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
por: Lin, Yu-Fang, et al.
Publicado: (2020)

CTNNB1 Mutation in Aldosterone Producing Adenoma
por: Wang, Jian-Jhong, et al.
Publicado: (2017)

The Relationship Between Renal Stones and Primary Aldosteronism
por: Chang, Chun-Kai, et al.
Publicado: (2022)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
por: Jędrusik, Piotr, et al.
Publicado: (2021)

Long term outcome of Aldosteronism after target treatments
por: Wu, Vin-Cent, et al.
Publicado: (2016)

Risk of sepsis in patients with primary aldosteronism
por: Chan, Chieh-Kai, et al.
Publicado: (2018)

Corrigendum: Long term outcome of Aldosteronism after target treatments
por: Wu, Vin-Cent, et al.
Publicado: (2017)

1-[4-(Iodomethyl)cyclohexyl]-4-methylbenzene
por: Wang, Juan, et al.
Publicado: (2011)

Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism
por: Fujimoto, Masanori, et al.
Publicado: (2023)

Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology
por: Chen, Yi-Ju, et al.
Publicado: (2022)

Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone
por: Wu, Che-Hsiung, et al.
Publicado: (2015)

Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy
por: Chang, Chia-Hui, et al.
Publicado: (2017)

Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma
por: Er, Leay Kiaw, et al.
Publicado: (2020)

Authors’ response to a letter to the Editor from Zhu et al. re: Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism
por: Lee, Ming-Jse, et al.
Publicado: (2021)

Crystal structures of two bis(iodomethyl)benzene derivatives: similarities and differences in the crystal packing
por: McAdam, C. John, et al.
Publicado: (2015)

Twenty-Four-Hour Urinary Aldosterone Predicts Inappropriate Left Ventricular Mass Index in Patients with Primary Aldosteronism
por: Hung, Chi-Sheng, et al.
Publicado: (2013)

The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study
por: Wu, Vin-Cent, et al.
Publicado: (2017)

Evaluation of right adrenal vein anatomy by Dyna computed tomography in patients with primary aldosteronism
por: Lee, Bo-Ching, et al.
Publicado: (2016)

The Influence of Antithyroid Drug Discontinuation to the Therapeutic Efficacy of (131)I in Hyperthyroidism
por: Kartamihardja, A. Hussein Sundawa, et al.
Publicado: (2016)

Non-stimulated adrenal venous sampling using Dyna computed tomography in patients with primary aldosteronism
por: Chang, Chin-Chen, et al.
Publicado: (2016)

Chemoselective O-Alkylation of 4-(Trifluoromethyl)pyrimidin-2(1H)-ones Using 4-(Iodomethyl)pyrimidines
por: Mittersteiner, Mateus, et al.
Publicado: (2022)

Characteristics of a Novel ATP2B3 K416_F418delinsN Mutation in a Classical Aldosterone-Producing Adenoma
por: Liao, Hung-Wei, et al.
Publicado: (2021)

Novel Mutations Detection with Next-Generation Sequencing and Its Association with Clinical Outcome in Unilateral Primary Aldosteronism
por: Wu, Che-Hsiung, et al.
Publicado: (2021)

Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC–MS/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol
por: Chang, Yu-Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tcl65atfrce5uplr126jqhfgkp